SLCTR/2017/003已完成4 期
Topiramate’s effectiveness on weight reduction in overweight/obese persons with Schizophrenia: A Randomized Controlled Trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosis of schizophrenia (International Classification of Diseases (ICD), 10th edition)
- •2. Age 18 years and above
- •3. Capacity to give informed consent (as determined by assessment of an external psychiatrist)
- •4. Body Mass Index above the cut-off for Asians, which is 23 kg/m2 by the World Health Organization
排除标准
- •1. Diabetes mellitus
- •2. Hypertension
- •3. Dyslipidaemia
- •4. Patients on other weight reducing agents
- •5. Patients with a significant loss of appetite leading to loss of more than 10% of body weight over a period of six months
- •6. Patients with difficulty in swallowing
- •7. Pregnant and lactating females
研究者
相似试验
已完成
3 期
Topiramate’s effectiveness on weight reduction and metabolic syndrome in obese patients with schizophrenia and schizoaffectiveIRCT20210622051665N1niversity of social welfare and rehabilitation sciences70
已完成
3 期
The effect of Topiramate on weight loss in Iranian patients with diabetes type 2Obesity.Obesity, unspecifiedIRCT201112036027N2Tehran University of Medical sciences80
已完成
不适用
Effect of Topiramate on body weight of patients with schizophrenia treated with OlanzapineSchizophrenia.SchizophreniaIRCT201402085280N15Mashhad University of Medical Sciences48
已完成
不适用
Therapeutic effect of Topiramate in refractory Obsessive Compulsive DisorderObcessive Compulsive Disorder.Obsessive Compulsive DisorderIRCT2013012312252N1Isfahan University Of Medical Sciences32
招募中
2 期
Evaluation of the effectiveness of topiramate in treating dependence of amphetamine and methamphetamine patientsIRCT20160417027437N2Ahvaz University of Medical Sciences60